133 related articles for article (PubMed ID: 22272617)
1. Hippocampal BDNF expression in a tau transgenic mouse model.
Burnouf S; Belarbi K; Troquier L; Derisbourg M; Demeyer D; Leboucher A; Laurent C; Hamdane M; Buee L; Blum D
Curr Alzheimer Res; 2012 May; 9(4):406-10. PubMed ID: 22272617
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
[TBL] [Abstract][Full Text] [Related]
3. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
[TBL] [Abstract][Full Text] [Related]
4. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.
Jiao SS; Shen LL; Zhu C; Bu XL; Liu YH; Liu CH; Yao XQ; Zhang LL; Zhou HD; Walker DG; Tan J; Götz J; Zhou XF; Wang YJ
Transl Psychiatry; 2016 Oct; 6(10):e907. PubMed ID: 27701410
[TBL] [Abstract][Full Text] [Related]
7. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
[TBL] [Abstract][Full Text] [Related]
8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
9. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.
Lahiani-Cohen I; Lourbopoulos A; Haber E; Rozenstein-Tsalkovich L; Abramsky O; Grigoriadis N; Rosenmann H
J Neuropathol Exp Neurol; 2011 Jul; 70(7):610-21. PubMed ID: 21666497
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
Belarbi K; Burnouf S; Fernandez-Gomez FJ; Laurent C; Lestavel S; Figeac M; Sultan A; Troquier L; Leboucher A; Caillierez R; Grosjean ME; Demeyer D; Obriot H; Brion I; Barbot B; Galas MC; Staels B; Humez S; Sergeant N; Schraen-Maschke S; Muhr-Tailleux A; Hamdane M; Buée L; Blum D
Neurobiol Dis; 2011 Aug; 43(2):486-94. PubMed ID: 21569847
[TBL] [Abstract][Full Text] [Related]
11. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
12. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
13. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
14. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
15. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
Belarbi K; Burnouf S; Fernandez-Gomez FJ; Desmercières J; Troquier L; Brouillette J; Tsambou L; Grosjean ME; Caillierez R; Demeyer D; Hamdane M; Schindowski K; Blum D; Buée L
Curr Alzheimer Res; 2011 Sep; 8(6):633-8. PubMed ID: 21605043
[TBL] [Abstract][Full Text] [Related]
16. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
17. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
18. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
[TBL] [Abstract][Full Text] [Related]
19. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
